According to @business, Novo Nordisk's Mike Doustdar lost a $10 billion takeover battle for obesity drug developer Metsera to Pfizer (PFE) (source: @business). According to @business, he is keeping deals on the table as the Danish company seeks to regain lost ground in the weight-loss boom (source: @business). According to @business, the report makes no mention of cryptocurrencies or digital assets and states no direct crypto-market linkage (source: @business).

According to @FoxNews, Pfizer has secured a $10 billion deal to acquire Metsera, ending a bidding war with Novo Nordisk and giving Pfizer a new foothold in the obesity-drug market, a headline relevant for traders focused on large-cap pharma and weight-loss treatment exposure (source: Fox News tweet; Fox Business report). The report did not cite any direct impact on cryptocurrency markets (source: Fox News tweet; Fox Business report).